Silence Therapeutics Ownership | Who Owns Silence Therapeutics?
Silence Therapeutics Ownership Summary
Silence Therapeutics is owned by 2.89% institutional investors, 24.38% insiders, and 72.74% retail investors. Tcg crossover management is the largest institutional shareholder, holding 6.42% of SLN shares. International Biotechnology Ord is the top mutual fund, with 1.54% of its assets in Silence Therapeutics shares.
SLN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Silence Therapeutics | 2.89% | 24.38% | 72.74% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tcg crossover management | 3.03M | 6.42% | $15.99M |
| Artal group | 2.78M | 6.32% | $52.81M |
| Siren | 2.91M | 6.16% | $15.34M |
| Redmile group | 2.16M | 4.58% | $11.41M |
| Nantahala capital management | 2.15M | 4.55% | $11.31M |
| Citadel advisors | 1.23M | 2.61% | $6.51M |
| Millennium management | 1.07M | 2.27% | $5.66M |
| Great point partners | 1.02M | 2.16% | $5.38M |
| Nextech invest | 952.40K | 2.02% | $5.02M |
| Ikarian capital | 865.78K | 1.83% | $1.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 2.78M | 1.35% | $52.81M |
| Great point partners | 1.02M | 1.24% | $5.38M |
| Nextech invest | 952.40K | 1.06% | $6.55M |
| M28 capital management lp | 101.20K | 0.99% | $533.34K |
| Redmile group | 2.16M | 0.76% | $11.41M |
| 5am venture management | 476.20K | 0.70% | $2.51M |
| Tfg asset management gp | 630.16K | 0.64% | $3.32M |
| Tcg crossover management | 3.03M | 0.46% | $15.99M |
| Siren | 2.91M | 0.43% | $15.34M |
| Nantahala capital management | 2.15M | 0.42% | $11.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Citadel advisors | 1.23M | 0.00% | 990.75K |
| Nantahala capital management | 2.15M | 0.42% | 604.30K |
| Millennium management | 1.07M | 0.00% | 414.60K |
| Tfg asset management gp | 630.16K | 0.64% | 264.79K |
| Great point partners | 1.02M | 1.24% | 212.46K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lombard odier asset management (europe) | - | - | -2.24M |
| Vivo capital | - | - | -1.11M |
| Janus henderson group | - | - | -1.09M |
| Polar capital | - | - | -1.00M |
| Deep track capital, lp | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Squarepoint ops | 89.47K | 0.00% | 89.47K | $471.50K |
| Dynamic technology lab private | 10.49K | 0.01% | 10.49K | $55.28K |
| Global retirement partners | 1.00K | 0.00% | 1.00K | $6.08K |
| Caitong asset management | 3.00 | - | 3.00 | $16.00 |
Sold Out
| Holder | Change |
|---|---|
| Advisor group | -3.00 |
| Eversource wealth advisors | -10.00 |
| Principal securities | -17.00 |
| Lazard asset management | -60.00 |
| Values first advisors | -3.09K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 19 | -67.80% | 1,363,594 | -92.46% | 2 | 0.02% | 12 | -57.14% | 4 | -76.47% |
| Dec 31, 2025 | 27 | -50.00% | 7,072,071 | -64.11% | 44 | 2.58% | 13 | -38.10% | 8 | -50.00% |
| Sep 30, 2025 | 53 | -7.02% | 16,670,893 | -15.69% | 35 | 18.12% | 21 | -8.70% | 16 | -15.79% |
| Jun 30, 2025 | 56 | -6.67% | 19,736,025 | -7.96% | 13 | 6.08% | 22 | -8.33% | 19 | -24.00% |
| Mar 31, 2025 | 60 | -9.09% | 21,913,755 | -11.60% | 15 | 4.95% | 23 | -39.47% | 25 | 92.31% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| International Biotechnology Ord | 729.62K | 1.54% | - |
| Eventide Healthcare & Life Sciences I | 640.00K | 1.36% | - |
| Polar Capital Biotech S Inc | 467.15K | 0.99% | -532.85K |
| MEDICAL BioHealth EUR Acc | 248.82K | 0.53% | -302.62K |
| apo Medical Opportunities R | 231.19K | 0.49% | -81.12K |
| iShares Biotechnology ETF | 170.79K | 0.36% | 1.08K |
| RIM Global Bioscience EUR | 147.96K | 0.31% | 12.00K |
| T. Rowe Price Health Sciences | 95.65K | 0.20% | 95.65K |
| BIT Biotech Opportunities S | 92.43K | 0.20% | -14.87K |
| Tema Obesity & Cardiometabolic ETF | 76.77K | 0.16% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 27, 2025 | Griffiths Richard Ian | - | Buy | $15.50K |
| Aug 03, 2025 | Griffiths Richard Ian | - | Buy | $109.00K |
| Oct 27, 2025 | Griffiths Richard Ian | - | Buy | $15.50K |
| Aug 03, 2025 | Griffiths Richard Ian | - | Buy | $109.00K |
| Aug 01, 2025 | Griffiths Richard Ian | - | Buy | $24.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 11 | - |
| 2025 Q2 | 37 | - |
| 2025 Q1 | 13 | - |
SLN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools